GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » PELL Bio-Med Technology Co Ltd (TPE:6949) » Definitions » Scaled Net Operating Assets

PELL Bio-Med Technology Co (TPE:6949) Scaled Net Operating Assets : 0.32 (As of Dec. 2024)


View and export this data going back to 2024. Start your Free Trial

What is PELL Bio-Med Technology Co Scaled Net Operating Assets?

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

PELL Bio-Med Technology Co's operating assets for the quarter that ended in Dec. 2024 was NT$608.66 Mil. PELL Bio-Med Technology Co's operating liabilities for the quarter that ended in Dec. 2024 was NT$93.78 Mil. PELL Bio-Med Technology Co's Total Assets for the quarter that ended in Sep. 2024 was NT$1,624.12 Mil. Therefore, PELL Bio-Med Technology Co's scaled net operating assets (SNOA) for the quarter that ended in Dec. 2024 was 0.32.

PELL Bio-Med Technology Co Scaled Net Operating Assets Historical Data

The historical data trend for PELL Bio-Med Technology Co's Scaled Net Operating Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

PELL Bio-Med Technology Co Scaled Net Operating Assets Chart

PELL Bio-Med Technology Co Annual Data
Trend Dec21 Dec22 Dec23 Dec24
Scaled Net Operating Assets
0.64 0.78 0.24 0.36

PELL Bio-Med Technology Co Quarterly Data
Dec21 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Scaled Net Operating Assets Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only 0.28 0.17 0.12 0.19 0.32

Competitive Comparison of PELL Bio-Med Technology Co's Scaled Net Operating Assets

For the Biotechnology subindustry, PELL Bio-Med Technology Co's Scaled Net Operating Assets, along with its competitors' market caps and Scaled Net Operating Assets data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

PELL Bio-Med Technology Co's Scaled Net Operating Assets Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, PELL Bio-Med Technology Co's Scaled Net Operating Assets distribution charts can be found below:

* The bar in red indicates where PELL Bio-Med Technology Co's Scaled Net Operating Assets falls into.


;
;

PELL Bio-Med Technology Co Scaled Net Operating Assets Calculation

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

PELL Bio-Med Technology Co's Scaled Net Operating Assets (SNOA) for the fiscal year that ended in Dec. 2024 is calculated as

Scaled Net Operating Assets (SNOA)(A: Dec. 2024 )
=(Operating Assets (A: Dec. 2024 )-Operating Liabilities (A: Dec. 2024 ))/Total Assets (A: Dec. 2023 )
=(608.655-93.777)/1418.156
=0.36

where

Operating Assets(A: Dec. 2024 )
=Total Assets - Cash, Cash Equivalents, Marketable Securities
=1744.832 - 1136.177
=608.655

Operating Liabilities(A: Dec. 2024 )
=Total Liabilities - Long-Term Debt & Capital Lease Obligation - Short-Term Debt & Capital Lease Obligation
=458.617 - 137.267 - 227.573
=93.777

PELL Bio-Med Technology Co's Scaled Net Operating Assets (SNOA) for the quarter that ended in Dec. 2024 is calculated as

Scaled Net Operating Assets (SNOA)(Q: Dec. 2024 )
=(Operating Assets (Q: Dec. 2024 )-Operating Liabilities (Q: Dec. 2024 ))/Total Assets (Q: Sep. 2024 )
=(608.655-93.777)/1624.121
=0.32

where

Operating Assets(Q: Dec. 2024 )
=Total Assets - Cash, Cash Equivalents, Marketable Securities
=1744.832 - 1136.177
=608.655

Operating Liabilities(Q: Dec. 2024 )
=Total Liabilities - Long-Term Debt & Capital Lease Obligation - Short-Term Debt & Capital Lease Obligation
=458.617 - 137.267 - 227.573
=93.777

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

PELL Bio-Med Technology Co Scaled Net Operating Assets Related Terms

Thank you for viewing the detailed overview of PELL Bio-Med Technology Co's Scaled Net Operating Assets provided by GuruFocus.com. Please click on the following links to see related term pages.

PELL Bio-Med Technology Co Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » PELL Bio-Med Technology Co Ltd (TPE:6949) » Definitions » Scaled Net Operating Assets
Comparable Companies
ROCO:4157 ROCO:6875 TPE:1760 ROCO:4726 ROCO:4178 TPE:4142 ROCO:4167 TPE:6657 TPE:1734 ROCO:6696 VRTX ASX:CSL REGN XKRX:207940 XBRU:ARGX XBRU:UCB ALNY ONC BNTX XKRX:068270
Traded in Other Exchanges
N/A
Address
No. 87, Xinhu 2nd Road, 4th Floor, Neihu District, Taipei, TWN
Website
https://www.pellbmt.com
PELL Bio-Med Technology Co Ltd is a company engaged in the research and development and application of autologous T Cell Therapy (Adoptive T Cell Therapy), CAR-T (Chimeric Antigen Receptor T cell), and Gene-Modified Adipose-Derived Stem Cell (Gene-Modified Adipose-Derived Stem Cell).

PELL Bio-Med Technology Co Headlines

No Headlines